Luca Gerosa, PhD, currently a principal scientist at Genentech in gRED Computational Sciences, pursued his undergraduate degree in computer science at the University of Trento, followed by a master’s in bioinformatics at the University of Edinburgh. He completed his PhD at ETH Zurich under Uwe Sauer, focusing on microbial metabolism through omics data integration, and later, a postdoctoral fellowship at Harvard Medical School with Peter Sorger, studying signaling dynamics and drug perturbations in cancer. At Genentech, he applies systems pharmacology approaches to develop targeted therapies for oncogenic signaling as well as pursues basic research in signaling networks and drug responses.
Luca Gerosa, PhD, currently a principal scientist at Genentech in gRED Computational Sciences, pursued his undergraduate degree in computer science at the University of Trento, followed by a master’s in bioinformatics at the University of Edinburgh. He completed his PhD at ETH Zurich under Uwe Sauer, focusing on microbial metabolism through omics data integration, and later, a postdoctoral fellowship at Harvard Medical School with Peter Sorger, studying signaling dynamics and drug perturbations in cancer. At Genentech, he applies systems pharmacology approaches to develop targeted therapies for oncogenic signaling as well as pursues basic research in signaling networks and drug responses.